SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-20-012797
Filing Date
2020-02-25
Accepted
2020-02-25 19:58:17
Documents
2
Period of Report
2020-02-21

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3860
2 POA DOCUMENT poa.txt EX-24.3_898226 4485
  Complete submission text file 0001209191-20-012797.txt   9828
Mailing Address 1035 O'BRIEN DRIVE MENLO PARK CA 94025
Business Address 1035 O'BRIEN DRIVE MENLO PARK CA 94025 650-272-6269
Adverum Biotechnologies, Inc. (Issuer) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ADVERUM BIOTECHNOLOGIES, INC. 1035 O'BRIEN DRIVE MENLO PARK CA 94025
Business Address
Thedinga Angela (Reporting) CIK: 0001804588 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36579 | Film No.: 20652959